Migratory Enhancement in Brain MRI of Rosette-forming Glioneuronal Tumour over 11 years
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
The Clinical and Molecular Landscape of Rosette-Forming Glioneuronal Tumors.
Yang Z, Zhang X Biomedicines. 2024; 12(10).
PMID: 39457636 PMC: 11505073. DOI: 10.3390/biomedicines12102325.
References
1.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A
. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109.
PMC: 1929165.
DOI: 10.1007/s00401-007-0243-4.
View
2.
Hockman J, El Tecle N, Urquiaga J, Alexopoulos G, Guzman M, Coppens J
. Dissemination Patterns and Short-Term Management of Multifocal Rosette-Forming Glioneuronal Tumors. World Neurosurg. 2021; 149:86-93.
DOI: 10.1016/j.wneu.2021.02.043.
View
3.
Lucas C, Gupta R, Doo P, Lee J, Cadwell C, Ramani B
. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor. Acta Neuropathol Commun. 2020; 8(1):151.
PMC: 7456392.
DOI: 10.1186/s40478-020-01027-z.
View
4.
Gaudino S, Quaglio F, Schiarelli C, Martucci M, Tartaglione T, Gualano M
. Spontaneous modifications of contrast enhancement in childhood non-cerebellar pilocytic astrocytomas. Neuroradiology. 2012; 54(9):989-95.
DOI: 10.1007/s00234-012-1010-3.
View